Palabras clave
COVID-19
Abuso de medicamentos
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Investigar las tendencias actuales y las implicaciones de la automedicación durante la pandemia de Covid-19, analizando los patrones de uso de medicamentos. Métodos: Revisión integradora de los últimos 05 años, utilizando los descriptores "Auto-medicación" y "Covid" en PubMed. Resultados: La búsqueda inicial arrojó 133 estudios, de los cuales 17 fueron considerados elegibles después de aplicar criterios de exclusión. Esta revisión reveló la prevalencia generalizada de la auto-medicación, impulsada por la ansiedad, el miedo y el pánico asociados con la pandemia, lo que llevó a un aumento global en las tasas de auto-medicación, incluso entre los profesionales de la salud. La población recurrió a diversas fuentes para obtener medicamentos, lo que resultó en el consumo de diferentes clases de fármacos para el alivio sintomático, a menudo ignorando los posibles riesgos asociados con el uso irracional de medicamentos. Consideraciones finales: Por lo tanto, es necesario que las autoridades tomen medidas para desalentar la auto-medicación. Se destacan estrategias como aumentar la conciencia sobre los riesgos asociados con la auto-medicación y alentar a la población a buscar servicios de atención médica para recibir orientación adecuada y tratamiento efectivo.
Referencias
ACHARYA A, et al. Self-medication among medical students and staffs of a Tertiary Care Centre during COVID-19 pandemic: a descriptive cross-sectional study. JNMA: Journal of the Nepal Medical Association, 2022; 60(245): 59.
AMENTA E, et al. A survey on self-medication for the prevention or treatment of COVID-19 and distrust in healthcare of veterans in a primary care setting in the United States. Therapeutic Advances in Drug Safety, 2022; 13: 20420986221143265.
ARIAS F, et al. A Cross-Sectional Analysis of Self-Medication Patterns during the COVID-19 Pandemic in Ecuador. Medicina, 2022; 58(11): 1678.
BATISTA EL. Grupo de médicos defende tratamento sem eficácia comprovada contra Covid-19 em jornais. In: FOLHA DE SÃO PAULO.2021; Disponível em: https ://www1.folha.uol.com.br/equilibrioesaude/2021/02/grupo-de-medicos-defende-tratamento-precoce-sem-eficacia-contra-covid-19-em-jornais.shtml.
CHAUDHRY B, et al. Factors Associated with Self-Medication during the COVID-19 Pandemic: A Cross-Sectional Study in Pakistan. Tropical medicine and infectious disease, 2022; 7(11): 330.
D’ARQOM A, et al. “Anti-COVID-19” medications, supplements, and mental health status in indonesian mothers with school-age children. International Journal of Women's Health, 2021; 699-709.
DAY RO, et al. The position of paracetamol in the world of analgesics. American Journal of Therapeutics, 2000; 7(2): 51-54.
ELAYEH E, et al. Prevalence and predictors of self‐medication drugs to prevent or treat COVID‐19: Experience from a Middle Eastern country. International journal of clinical practice,2021; 75(11): 14860.
FURTADO RHM, et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. The Lancet, 2020; 396(10256): 959-967.
GAVIRIA-MENDOZA A, et al. Self-medication and the ‘infodemic’during mandatory preventive isolation due to the COVID-19 pandemic. Therapeutic Advances in Drug Safety,2022; 13: 20420986221072376.
GERBIER A, et al. Self-reported medication use among pregnant and postpartum women during the third wave of the COVID-19 pandemic: A European multinational cross-sectional study. International journal of environmental research and public health, 2022; 19(9): 5335.
GRANT WB, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients,2020; 12(4): 988.
ISLAM MDS, et al. Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh. International journal of environmental research and public health, 2021; 18(4): 1453.
KASSIE AD, et al. Self-medication practice and associated factors among adult household members in Meket district, Northeast Ethiopia, 2017. BMC Pharmacology and Toxicology, 2018; 19(1): 1-8.
KIM HK, et al. Effects of COVID-19 misinformation on information seeking, avoidance, and processing: A multicountry comparative study. Science Communication, 2020; 42(5): 586-615.
KIM MS, et al. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis. PLoS medicine, 2020; 17(12): 1003501.
KIMATHI G, et al. A cross-sectional study of antimicrobial use among self-medicating COVID-19 cases in Nyeri County, Kenya. Antimicrobial Resistance & Infection Control, 2022; 11(1): 1-12.
KINDZEKA ME. Hundreds Rush for Popular Cleric’s Herbal COVID « Cure » In: CAMEROON. 2020. Availeble from: https ://www.voanews.com/covid-19-pandemic/hundreds-rush-popular-clerics-herbal-covid-cure-cameroon.
MAHMOUDI H. Assessment of knowledge, attitudes, and practice regarding antibiotic self-treatment use among COVID-19 patients. GMS Hygiene and Infection Control, 2022; 17.
MORGAN DJ e OKEKE IN. Laxminarayan Ret al. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis, 2011; 11: 692-701.
ONCHONGA D, et al. Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya. Saudi Pharmaceutical Journal, 2020; 28(10): 1149-1154.
OKOYE OC, et al. Self medication practices and its determinants in health care professionals during the coronavirus disease-2019 pandemic: cross-sectional study. International journal of clinical pharmacy,2022; 44(2): 507-516.
ORGANIZAÇÃO MUNDIAL DA SAÚDE. Guidelines for the regulatory assessment of medicinal products for use in self-medication. World Health Organization, 2000.
PAN H, et al. Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results. Lancet, 2022; 399: 1941-1953.
PARULEKAR M, et al. Self medication in developing countries a systematic review. 2016.
QUISPE-CAÑARI JF, et al. Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. Saudi pharmaceutical journal, 2021; 29(1): 1-11.
RANGARI GM. et al. Prevalence of self-medication in rural area of Andhra Pradesh. Journal of Family Medicine and Primary Care, 2020; 9(6): 2891.
RECOVERY COLLABORATIVE GROUP. Dexamethasone in hospitalized patients with Covid-19. New England Journal of Medicine,2021; 384(8): 693-704.
ROMANO S, et al. Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies. Research in Social and Administrative Pharmacy, 2021; 17(1): 1876-1881.
RUIZ-PADILLA AJ, et al. Use of allopathic and complementary medicine for preventing SARS-CoV-2 infection in Mexican adults: a national survey. Saudi Pharmaceutical Journal,2021; 29(9): 1056-1060.
SADIO AJ, et al. Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo. BMC public health, 2021; 21(1): 1-9.
SADO E, et al. Epidemiology of self-medication with modern medicines among health care professionals in Nekemte town, western Ethiopia. BMC research notes, 2017; 10(1): 1-5.
SHEHNAZ SI, et al. A systematic review of self-medication practices among adolescents. Journal of adolescent health,2014; 55(4): 467-483.
SILVA DG, et al. Possíveis tratamentos farmacológicos em fase de estudos para pacientes sintomáticos de COVID-19: Uma revisão integrativa. Pesquisa, Sociedade e Desenvolvimento, 2021; 10(6): 37910615579-37910615579.
THOMAS S, et al. Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial. JAMA network open, 2021; 4(2): 210369-210369.
TOURE A, et al. Self-medication against COVID-19 in health workers in Conakry, Guinea. Journal of Public Health in Africa, 2022; 13(2).
VALLEJOS J, et al. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial. BMC infectious diseases, 2021; 21(1): 11.
VASQUEZ-ELERA LE, et al. Self-medication in hospitalized patients with COVID-19: A cross-sectional study in northern Peru. Germs, 2022; 12(1): 46.
WEGBOM AI, et al. Self-medication practices and associated factors in the prevention and/or treatment of COVID-19 virus: a population-based survey in Nigeria. Frontiers in public health, 2021; 9: 606801.
ZHANG A, et al. Self-medication with antibiotics for protection against COVID-19: the role of psychological distress, knowledge of, and experiences with antibiotics. Antibiotics, 2021; 10(3): 232.